| Style | Citing Format |
|---|---|
| MLA | Tahamtan A, et al.. "Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option." Frontiers in Immunology, vol. 14, no. , 2023, pp. -. |
| APA | Tahamtan A, Samadizadeh S, Salimi V, Natarelli L, Nakstad B (2023). Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option. Frontiers in Immunology, 14(), -. |
| Chicago | Tahamtan A, Samadizadeh S, Salimi V, Natarelli L, Nakstad B. "Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option." Frontiers in Immunology 14, no. (2023): -. |
| Harvard | Tahamtan A et al. (2023) 'Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option', Frontiers in Immunology, 14(), pp. -. |
| Vancouver | Tahamtan A, Samadizadeh S, Salimi V, Natarelli L, Nakstad B. Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option. Frontiers in Immunology. 2023;14():-. |
| BibTex | @article{ author = {Tahamtan A and Samadizadeh S and Salimi V and Natarelli L and Nakstad B}, title = {Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option}, journal = {Frontiers in Immunology}, volume = {14}, number = {}, pages = {-}, year = {2023} } |
| RIS | TY - JOUR AU - Tahamtan A AU - Samadizadeh S AU - Salimi V AU - Natarelli L AU - Nakstad B TI - Editorial: Mirnas and Inflammation: From Biogenesis to Therapeutic Option JO - Frontiers in Immunology VL - 14 IS - SP - EP - PY - 2023 ER - |